12 Health Care Stocks Moving In Tuesday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.During Tuesday's pre-market session, several healthcare stocks showed significant movement. Gainers included iSpecimen (up 22.7%), Bluejay Diagnostics (up 22.53%), Pharvaris (up 19.12%), Roivant Sciences (up 18.49%), Atara Biotherapeutics (up 9.83%), and Jin Medical International (up 9.08%). Conversely, losers featured Dyne Therapeutics (down 28.8%), bioAffinity Technologies (down 24.69%), Onconetix (down 18.63%), Lexaria Bioscience (down 17.96%), Jaguar Health (down 17.25%), and Pomdoctor (down 15.67%).
Gainers
- iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million.
- Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 22.53% to $1.02.
- Pharvaris (NASDAQ:PHVS) stock rose 19.12% to $41.99. The company's market cap stands at $2.4 billion.
- Roivant Sciences (NASDAQ:ROIV) stock rose 18.49% to $41.39. The company's market cap stands at $25.2 billion.
- Atara Biotherapeutics (NASDAQ:ATRA) stock moved upwards by 9.83% to $10.72. The company's market cap stands at $97.9 million.
- Jin Medical International (NASDAQ:ZJYL) shares increased by 9.08% to $2.27. The market value of their outstanding shares is at $16.2 million.
Losers
- Dyne Therapeutics (NASDAQ:DYN) shares fell 28.8% to $17.3 during Tuesday's pre-market session. The company's market cap stands at $4.5 billion.
- bioAffinity Technologies (NASDAQ:BIAF) stock declined by 24.69% to $11.5. The company's market cap stands at $9.1 million.
- Onconetix (NASDAQ:ONCO) shares fell 18.63% to $0.83. The market value of their outstanding shares is at $4.4 million.
- Lexaria Bioscience (NASDAQ:LEXX) shares fell 17.96% to $11.61. The company's market cap stands at $23.3 million.
- Jaguar Health (NASDAQ:JAGX) stock fell 17.25% to $0.49. The company's market cap stands at $3.0 million.
- Pomdoctor (NASDAQ:POM) stock declined by 15.67% to $0.7. The company's market cap stands at $7.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.